Brief: Prometheus Biosciences Reports First Quarter 2023 Financial Results
09/05/2023 21:20
May 9 (Reuters) - Prometheus Biosciences Inc RXDX.O :
* PROMETHEUS BIOSCIENCES REPORTS FIRST QUARTER 2023
FINANCIAL
RESULTS AND HIGHLIGHTS RECENT CORPORATE PROGRESS
* QTRLY LOSS PER SHARE $0.86
* Q1 EARNINGS PER SHARE VIEW $-0.91 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX8kr3Yy
Further company coverage: RXDX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Prometheus Biosciences
See all newsBrief: Prometheus Biosciences - Completed Merger Of Splash Merger Sub, Unit Of Merck & Co
Analysis: Amgen's antitrust woes spur wider pharmaceutical deal fears
William Blair sees FTC suit on Amgen-Horizon deal weighing on biotech M&A sentiment
FTC scrutiny to block Amgen-Horizon deal drags down Seagen, Prometheus
Brief: Prometheus Biosciences Reports First Quarter 2023 Financial Results